Bone Marrow Progenitor Cell Mobilization in Diabetes
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Bone Marrow Progenitor Cell Mobilization in Diabetes is a clinical trial[1].
Key Facts
- Bone Marrow Progenitor Cell Mobilization in Diabetes is in the country of Italy[2].
- Bone Marrow Progenitor Cell Mobilization in Diabetes's instance of is recorded as clinical trial[3].
- Bone Marrow Progenitor Cell Mobilization in Diabetes's start time is recorded as +2010-06-30T00:00:00Z[4].
- Bone Marrow Progenitor Cell Mobilization in Diabetes's end time is recorded as +2013-08-31T00:00:00Z[5].
- Bone Marrow Progenitor Cell Mobilization in Diabetes's main subject is recorded as diabetes[6].
- Bone Marrow Progenitor Cell Mobilization in Diabetes's number of participants is recorded as {'unit': '1', 'amount': '+48'}[7].
- Bone Marrow Progenitor Cell Mobilization in Diabetes's title is recorded as Bone Marrow Responsiveness to Pharmacologic Mobilization of Progenitor Cells in Diabetic Versus Non-diabetic Patients[8].
- Bone Marrow Progenitor Cell Mobilization in Diabetes's short name is recorded as GCSF-DM[9].
- Bone Marrow Progenitor Cell Mobilization in Diabetes's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+25'}[10].
- Bone Marrow Progenitor Cell Mobilization in Diabetes's ClinicalTrials.gov ID is recorded as NCT01102699[11].
- Bone Marrow Progenitor Cell Mobilization in Diabetes's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}[12].
- Bone Marrow Progenitor Cell Mobilization in Diabetes's research intervention is recorded as lenograstim[13].
- Bone Marrow Progenitor Cell Mobilization in Diabetes's clinical trial phase is recorded as phase IV clinical trial[14].
- Bone Marrow Progenitor Cell Mobilization in Diabetes's research subject recruitment status is recorded as completed[15].
- Bone Marrow Progenitor Cell Mobilization in Diabetes's study type is recorded as interventional study[16].